Tissue histopathology, clinical chemistry and behaviour of adult Comt-gene-disrupted mice

Kristiina Haasio1, Marko Huotari, Erkki Nissinen

  • 1Orion Corporation, Orion Pharma Research and Development, PO Box 65, FIN-02101 Espoo, Finland. kristiina.haasio@orionpharma.com

Insights

Disrupting the Catechol-O-methyltransferase (COMT) gene in mice did not lead to toxic effects, despite concerns about COMT activity and cancer. These Comt-gene-disrupted mice showed no significant health issues or organ damage.

Area of Science:

  • Biochemistry
  • Genetics
  • Toxicology

Background:

  • Catechol-O-methyltransferase (COMT) is crucial for metabolizing catecholamines and catechol estrogens.
  • Concerns exist regarding low COMT activity's link to estrogen-dependent cancers and COMT inhibitor toxicity.

Purpose of the Study:

  • To investigate the histopathology and clinical chemistry of Comt-gene-disrupted mice to assess potential toxic consequences of COMT deficiency.

Main Methods:

  • Studied Comt-gene-disrupted mice (heterozygous and homozygous) at 12 months of age.
  • Evaluated physical health, fertility, behavior, body weight, and performed macroscopic and histopathological examinations.
  • Analyzed clinical chemistry parameters, hematology, and plasma catecholamine and metabolite levels.

Main Results:

  • Comt-gene-disrupted mice were healthy, fertile, and exhibited normal behavior.
  • Homozygous mice had slightly lower body weight and reduced liver vacuolation.
  • Clinical chemistry values were within physiological ranges, and no significant histopathological findings were observed across genotypes.

Conclusions:

  • Complete or partial lack of Comt gene function in mice is not associated with overt toxic consequences or significant histopathological changes.
  • Further research may be warranted to fully elucidate COMT's role in health and disease, particularly concerning estrogen metabolism.